Barclays PLC Oncorus, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.24 - $0.76 $207 - $658
-866 Reduced 8.36%
9,495 $2,000
Q3 2022

Nov 03, 2022
SELL
$0.85 - $1.65 $543 - $1,054
-639 Reduced 5.81%
10,361 $9,000
Q2 2022

Aug 12, 2022
SELL
$1.04 - $1.86 $2,195 - $3,926
-2,111 Reduced 16.1%
11,000 $14,000
Q1 2022

May 16, 2022
BUY
$1.44 - $5.62 $18,879 - $73,683
13,111 New
13,111 $23,000

About Oncorus, Inc.

ONCR Quotes by TradingView
  • Ticker ONCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,973,100
  • Description
  • Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...
More about ONCR
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email